{
    "id": 23926,
    "fullName": "PDGFRA Y849S",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "PDGFRA Y849S lies within the protein kinase domain of the Pdgfra protein (UniProt.org). Y849S results in constitutive phosphorylation of Pdgfra and Stat5, increased cell proliferation, and is transforming in cell culture (PMID: 21224473).",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 418,
                    "pubMedId": 21224473,
                    "title": "Novel imatinib-sensitive PDGFRA-activating point mutations in hypereosinophilic syndrome induce growth factor independence and leukemia-like disease.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/21224473"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 5156,
        "geneSymbol": "PDGFRA",
        "terms": [
            "PDGFRA",
            "CD140A",
            "PDGFR-2",
            "PDGFR2"
        ]
    },
    "variant": "Y849S",
    "createDate": "06/29/2016",
    "updateDate": "06/29/2016",
    "referenceTranscriptCoordinates": {
        "id": 119131,
        "transcript": "NM_006206",
        "gDna": "chr4:g.54285947A>C",
        "cDna": "c.2546A>C",
        "protein": "p.Y849S",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 7417,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Gleevec (imatinib) inhibited growth of transformed mouse myeloid cells over expressing PDGFRA Y849S in culture (PMID: 21224473).",
            "molecularProfile": {
                "id": 24650,
                "profileName": "PDGFRA Y849S"
            },
            "therapy": {
                "id": 770,
                "therapyName": "Imatinib",
                "synonyms": null
            },
            "indication": {
                "id": 8692,
                "name": "myeloid leukemia",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 418,
                    "pubMedId": 21224473,
                    "title": "Novel imatinib-sensitive PDGFRA-activating point mutations in hypereosinophilic syndrome induce growth factor independence and leukemia-like disease.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/21224473"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 7420,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Gleevec (imatinib) inhibited Pdgfra phosphorylation and cell proliferation in transformed cells over expressing PDGFRA Y849S in culture (PMID: 21224473).",
            "molecularProfile": {
                "id": 24650,
                "profileName": "PDGFRA Y849S"
            },
            "therapy": {
                "id": 770,
                "therapyName": "Imatinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 418,
                    "pubMedId": 21224473,
                    "title": "Novel imatinib-sensitive PDGFRA-activating point mutations in hypereosinophilic syndrome induce growth factor independence and leukemia-like disease.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/21224473"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 24650,
            "profileName": "PDGFRA Y849S",
            "profileTreatmentApproaches": [
                {
                    "id": 9900,
                    "name": "PDGFR-alpha Inhibitor",
                    "profileName": "PDGFRA Y849S"
                },
                {
                    "id": 9899,
                    "name": "PDGFR Inhibitor (Pan)",
                    "profileName": "PDGFRA Y849S"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 119133,
            "transcript": "XM_011534385",
            "gDna": "chr4:g.54285947A>C",
            "cDna": "c.2546A>C",
            "protein": "p.Y849S",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 119131,
            "transcript": "NM_006206",
            "gDna": "chr4:g.54285947A>C",
            "cDna": "c.2546A>C",
            "protein": "p.Y849S",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 119132,
            "transcript": "XM_005265743",
            "gDna": "chr4:g.54285947A>C",
            "cDna": "c.2546A>C",
            "protein": "p.Y849S",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}